Request for Covid-19 Impact Assessment of this Report
Proteomics is the study of structure and functions of proteins. After the advent of genomics and transcriptomics, proteomics was the next step in the study of biological systems. It is a complex study when compared to genomics, as an organism's genome is constant, while the proteome differs with cells and time.
The proteomics market has experienced a striking growth in the past few years as these have been found to be extremely beneficial in the diagnosis of diseases and identification of potential new drugs for the treatment of diseases. Factors such as the rise in focus of the key players, increase in R&D expenditure on proteomics, increase in popularity for personalized medicines, and technological advancements in proteomics are set to drive the market. However, stringent regulatory approvals, high cost of the instruments, and dearth of qualified researchers are expected to restrain the growth of the market. The global proteomics market is expected to reach $44,452 million by 2022 from $17,988 million in 2015 at a CAGR of 13.7%
The global proteomics market is segmented into instruments, reagents, and services. Based on technology, the instruments segment is further divided into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, X-ray crystallography, and protein fractionation systems. In the year 2015, protein microarrays accounted for the highest market share of instruments markets followed by spectrometry. In the reagents segment, immunoassays dominated the market in 2015, followed by spectroscopy and microarray reagents. On the basis of applications, the market is segmented in drug discovery, disease diagnosis, and others. Drug discovery was the largest application of proteomics in 2015. Geographically, the market is divided into North America, Europe, Asia-Pacific, and LAMEA. In the year 2015, North America accounted for highest market share, owing to higher popularity of the technology, high cost of instruments, and high funding from the government and organizations such as National Institutes of Health (NIH) and National Science Foundation (NSF). Asia-Pacific is expected to witness fastest growth rate during the study period, owing to increase in government and corporate funding for R&D.
Over the past few years, the most important strategy followed by the leading companies was mergers & acquisitions. For instance, Thermo Fisher Scientific acquired Affymetrix Inc. (May 2016), and Life Technologies (February 2014) and Merck & Co., Inc. acquired Sigma-Aldrich (November 2015).
KEY MARKET BENEFITS:
KEY MARKET SEGMENTS:
By Components
By Application
By Geography
Key players profiled in the report
Other companies in the value chain (profiles not included)
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition & scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Recent developments in the field of proteomics
3.3.1 Two dimensional electrophoresis
3.3.2 Advances in mass spectrometry
3.3.3 Reagents and kits
3.3.4 Chromatography technology
3.3.5 Data analysis
3.4 Player positioning, 2015
3.5 Market Dynamics
3.5.1 Drivers
3.5.1.1 Increasing popularity of personalized medicine is driving the demand for proteomic technologies
3.5.1.2 Increasing research & development expenditure to drive the proteomics market
3.5.1.3 Technological advancements to drive the proteomics market
3.5.1.4 Proteomics help to bridge the gap between the understanding of genome expression and cellular behavior
3.5.2 Restraints
3.5.2.1 High cost of instruments
3.5.2.2 Dearth of skilled researchers
3.5.3 Opportunities
3.5.3.1 Developments in mass spectrometry-based proteomic strategies
3.5.3.2 Identification of biomarker offers significant opportunities
CHAPTER 4 WORLD PROTEOMICS MARKET, BY COMPONENT
4.1 Overview
4.1.1 Market size and forecast
4.2 Instruments
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Protein microarray
4.2.5 Spectrometry
4.2.5.1 Mass spectroscopy
4.2.5.2 NMR spectroscopy
4.2.6 Chromatography
4.2.6.1 HPLC systems
4.2.6.2 Ion chromatography
4.2.6.3 Affinity chromatography
4.2.6.4 Supercritical Fluid Chromatography
4.2.7 Electrophoresis
4.2.7.1 Gel electrophoresis
4.2.7.2 Capillary electrophoresis
4.2.8 Surface Plasmon Resonance
4.2.9 X-ray crystallography
4.2.10 Protein Fractionation Systems
4.3 Reagents
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Microarray
4.3.5 Spectroscopy
4.3.6 X-Ray Crystallography
4.3.7 Chromatography
4.3.8 Electrophoresis
4.3.9 Immunoassay
4.3.10 Protein Fractionation Reagents
4.4 Services market
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
CHAPTER 5 WORLD PROTEOMICS MARKET, BY APPLICATION, 2014-2022
5.1 Overview
5.1.1 Market size and forecast
5.2 Drug Discovery
5.2.1 Market size and forecast
5.3 Disease Diagnosis
5.3.1 Market size and forecast
5.4 Other Applications
5.4.1 Market size and forecast
CHAPTER 6 WORLD PROTEOMICS MARKET, BY GEOGRAPHY, 2014-2022
6.1 Overview
6.2 North America
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U.S.
6.2.5 Canada
6.2.6 Mexico
6.3 Europe
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany
6.3.5 France
6.3.6 UK
6.3.7 Italy
6.3.8 Spain
6.3.9 Rest of Europe
6.4 Asia Pacific
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Japan
6.4.5 China
6.4.6 India
6.4.7 South Korea
6.4.8 Australia
6.4.9 Rest of Asia-Pacific
6.5 LAMEA
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Brazil
6.5.5 Isreal
6.5.6 Saudi Arabia
6.5.7 South Africa
6.5.8 Rest of LAMEA
CHAPTER 7 COMPANY PROFILES
7.1 Agilent Technologies, Inc.
7.1.1 Company Overview
7.1.2 Company Snapshot
7.1.3 Operating business segments
7.1.4 Business performance
7.1.5 Key Strategic Moves & Developments
7.2 Bio-Rad Laboratories, Inc.
7.2.1 Company Overview
7.2.2 Company Snapshot
7.2.3 Operating business segments
7.2.4 Business performance
7.3 Bruker Corporation
7.3.1 Company Overview
7.3.2 Company Snapshot
7.3.3 Operating business segments
7.3.4 Business performance
7.3.5 Key Strategic Moves & Developments
7.4 Caprion Proteomics Inc.
7.4.1 Company Overview
7.4.2 Company Snapshot
7.4.3 Operating business segments
7.5 Danaher Corporation
7.5.1 Company Overview
7.5.2 Company Snapshot
7.5.3 Operating Business Segments
7.5.4 Business Performance
7.5.5 Key Strategic Moves & Developments
7.6 General Electric Co.
7.6.1 Company overview
7.6.2 GE: SNAPSHOT
7.6.3 Operating business segments overview
7.6.4 Business performance
7.6.5 Key Strategic moves & developments
7.7 LUMINEX CORPORATION
7.7.1 Company Overview
7.7.2 Company Snapshot
7.7.3 Operating business segments
7.7.4 Business performance
7.7.5 Key Strategic Moves & Developments
7.8 THERMO FISHER SCIENTIFIC INC.
7.8.1 Company Overview
7.8.2 Company Snapshot
7.8.3 Operating business segments
7.8.4 Business performance
7.8.5 Key Strategic Moves & Developments
7.9 Waters Corporation
7.9.1 Company Overview
7.9.2 Company Snapshot
7.9.3 Operating business segments
7.9.4 Business performance
7.9.5 Key Strategic Moves & Developments
7.10 PerkinElmer, Inc.
7.10.1 Company Overview
7.10.2 Company Snapshot
7.10.3 Operating business segments
7.10.4 Business performance
List of Figures
FIG. 1 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2012-2016
FIG. 2 PLAYER POSITIONING, 2015
FIG. 3 TOP IMPACTING FACTORS: WORLD PROTEOMICS MARKET, 2015-2022
FIG. 4 WORLD PROTEOMICS MARKET FOR PROTEIN MICROARRAY ($MILLION), 2014-2022
FIG. 5 WORLD PROTEOMICS MARKET FOR MASS SPECTROMETRY ($MILLION), 2014-2022
FIG. 6 WORLD PROTEOMICS MARKET FOR NMR SPECTROSCOPY ($MILLION), 2014-2022
FIG. 7 WORLD PROTEOMICS MARKET FOR HPLC SYSTEMS ($MILLION), 2014-2022
FIG. 8 WORLD PROTEOMICS MARKET FOR ION CHROMATOGRAPHY ($MILLION), 2014-2022
FIG. 9 WORLD PROTEOMICS MARKET FOR AFFINITY CHROMATOGRAPHY ($MILLION), 2014-2022
FIG. 10 WORLD PROTEOMICS MARKET FOR SUPERCRITICAL FLUID CHROMATOGRAPHY ($MILLION), 2014-2022
FIG. 11 WORLD PROTEOMICS MARKET FOR GEL ELECTROPHORESIS ($MILLION), 2014-2022
FIG. 12 WORLD PROTEOMICS MARKET FOR CAPILLARY ELECTROPHORESIS ($MILLION), 2014-2022
FIG. 13 WORLD PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE ($MILLION), 2014-2022
FIG. 14 WORLD PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY ($MILLION), 2014-2022
FIG. 15 WORLD PROTEOMICS MARKET FOR PROTEIN FRACTIONATION SYSTEMS ($MILLION), 2014-2022
FIG. 16 WORLD PROTEOMICS MARKET FOR MICROARRAY REAGENTS, 2014-2022 ($MILLION)
FIG. 17 WORLD PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, 2014-2022 ($MILLION)
FIG. 18 WORLD PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS ($MILLION), 2014-2022
FIG. 19 WORLD PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS ($MILLION), 2014-2022
FIG. 20 WORLD PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS ($MILLION), 2014-2022
FIG. 21 WORLD PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS ($MILLION), 2014-2022
FIG. 22 WORLD PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS ($MILLION), 2014-2022
FIG. 23 WORLD PROTEOMICS MARKET FOR SERVICES ($MILLION), 2014-2022
FIG. 24 WORLD PROTEOMICS MARKET FOR DRUG DISCOVERY ($MILLION), 2014-2022
FIG. 25 WORLD PROTEOMICS MARKET FOR DISEASE DIAGNOSIS ($MILLION), 2014-2022
FIG. 26 WORLD PROTEOMICS MARKET FOR OTHER APPLICATIONS ($MILLION), 2014-2022
FIG. 27 U.S. PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 28 CANADA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 29 MEXICO PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 30 GERMANY PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 31 FRANCE PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 32 UK PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 33 ITALY PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 34 SPAIN PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 35 REST OF EUROPE PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 36 JAPAN PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 37 CHINA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 38 INDIA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 39 SOUTH KOREA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 40 AUSTRALIA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 41 REST OF ASIA-PACIFC PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 42 BRAZIL PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 43 ISRAEL PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 44 SOUTH AFRICA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 45 SAUDI ARABIA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 46 REST OF LAMEA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 47 AGILENT TECHNOLOGIES - NET SALES ($MILLION), 2013-2015
FIG. 48 AGILENT TECHNOLOGIES - NET SALES, BY SEGMENT, 2015 (%)
FIG. 49 AGILENT TECHNOLOGIES - NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 50 BIO-RAD - NET SALES, 2013-2015 ($MILLION)
FIG. 51 BIO-RAD - NET SALES, BY SEGMENT, 2015 (%)
FIG. 52 BIO-RAD - NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 53 BRUKER CORPORATION - NET SALES ($MILLION), 2013-2015
FIG. 54 BRUKER CORPORATION - NET SALES, BY SEGMENT, 2015 (%)
FIG. 55 BRUKER CORPORATION - NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 56 DANAHER - NET SALES ($MILLION), 2013-2015
FIG. 57 DANAHER - NET SALES, BY SEGMENT, 2015 (%)
FIG. 58 DANAHER - NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 59 GE - NET SALES ($MILLION), 2013-2015
FIG. 60 GE - NET SALES, BY SEGMENT, 2015 (%)
FIG. 61 GE - NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 62 LUMINEX - NET SALES ($MILLION), 201-2016
FIG. 63 LUMINEX - REVENUE, BY SEGMENT, 2016 (%)
FIG. 64 LUMINEX - NET SALES, BY GEOGRAPHY, 2016 (%)
FIG. 65 THERMO FISHER - NET SALES ($MILLION), 2013-2015
FIG. 66 THERMO FISHER - NET SALES, BY SEGMENT, 2015 (%)
FIG. 67 THERMO FISHER - NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 68 WATERS CORPORATION - NET SALES, ($MILLION), 2013-2015
FIG. 69 WATERS CORPORATION - NET SALES, BY SEGMENT, 2015 (%)
FIG. 70 WATERS CORPORATION - NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 71 PERKINELMER - TOTAL SALES ($MILLION), 2013-2015
FIG. 72 PERKINELMER - REVENUE, BY SEGMENT, 2015 (%)
FIG. 73 PERKINELMER - NET SALES, BY GEOGRAPHY, 2015 (%)
List of Tables
TABLE 1 WORLD PROTEOMICS MARKET, BY COMPONENT ($MILLION), 2014-2022
TABLE 2 WORLD PROTEOMICS MARKET FOR INSRUMENTS, BY TYPE ($MILLION), 2014-2022
TABLE 3 WORLD PROTEOMICS MARKET FOR SPECTROMETRY, BY TYPE ($MILLION), 2014-2022
TABLE 4 WORLD PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE ($MILLION), 2014-2022
TABLE 5 WORLD PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE ($MILLION), 2014-2022
TABLE 6 WORLD PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE ($MILLION), 2014-2022
TABLE 7 WORLD PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY ($MILLION), 2014-2022
TABLE 8 WORLD PROTEOMICS MARKET FOR PROTEIN FRACTIONATION SYSTEMS ($MILLION), 2014-2022
TABLE 9 WORLD PROTEOMICS MARKET FOR REAGENTS, BY TYPE ($MILLION), 2014-2022
TABLE 10 WORLD PROTEOMICS MARKET, BY APPLICATION ($MILLION), 2014-2022
TABLE 11 WORLD PROTEOMICS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 12 WORLD PROTEOMICS MARKET FOR INSTRUMENTS, BY REGION ($MILLION), 2014-2022
TABLE 13 WORLD PROTEOMICS MARKET FOR REAGENTS, BY REGION ($MILLION), 2014-2022
TABLE 14 WORLD PROTEOMICS MARKET FOR SERVICES, BY REGION ($MILLION), 2014-2022
TABLE 15 NORTH AMERICA PROTEOMICS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 16 NORTH AMERICA PROTEOMICS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 17 EUROPE PROTEOMICS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 18 EUROPE PROTEOMICS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 19 ASIA-PACIFIC PROTEOMICS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 20 ASIA-PACIFIC PROTEOMICS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 21 LAMEA PROTEOMICS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 22 LAMEA PROTEOMICS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 23 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 24 AGILENT TECHNOLOGIES - OPERATING SEGMENTS
TABLE 25 BIO-RAD - COMPANY SNAPSHOT
TABLE 26 BIO-RAD - OPERATING SEGMENTS
TABLE 27 BRUKER CORPORATION - COMPANY SNAPSHOT
TABLE 28 BRUKER CORPORATION: OPERATING SEGMENTS
TABLE 29 CAPRION PROTEOMICS - COMPANY SNAPSHOT
TABLE 30 CAPRION - OPERATING SEGMENTS
TABLE 31 DANAHER - COMPANY SNAPSHOT
TABLE 32 DANAHER - OPERATING SEGMENTS
TABLE 33 GE - COMPANY SNAPSHOT
TABLE 34 GE: OPERATING SEGMENTS
TABLE 35 LUMINEX - COMPANY SNAPSHOT
TABLE 36 LUMINEX - OPERATING SEGMENTS
TABLE 37 THERMO FISHER - COMPANY SNAPSHOT
TABLE 38 THERMO FISHER - OPERATING SEGMENTS
TABLE 39 WATERS CORPORATION - COMPANY SNAPSHOT
TABLE 40 WATER CORPORATION - OPERATING SEGMENTS
TABLE 41 PERKINELMER - COMPANY SNAPSHOT
TABLE 42 PERKINELMER - OPERATING SEGMENTS
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...